Drug
Ro7062931
Ro7062931: highest development phase Phase 1, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| RO7062931 NCT03505190 | Phase 1 | Healthy Participants |
Latest
No recent events.
Follow Ro7062931 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.